Switching from TDF to TAF associated with improvements in bone mineral density in people over 60
Point-of-care viral load testing results in more switches from failing treatment
Directly observed therapy can be a useful tool in caring for people with HIV treatment failure
Without frequent viral load monitoring dolutegravir-based regimens not the best choice for African youth on failing ART
Fostemsavir salvage therapy continues to look good at 96 weeks
Dolutegravir dual therapy works well for both first line and maintenance treatment
Four days on, three days off HIV treatment as effective as continuous therapy, French study finds
